19 June - 21 June 2024

3rd Symposium on New Therapeutics for Global Health

Organised by:

SCI's Fine Chemicals Group, RSC's Biological & Medicinal Chemistry Sector and SEQT (The Spanish Society of Medicinal Chemistry)

GlaxoSmithKline, Spain

Register your interest

Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (e.g. dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.


This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation.


The full programme will be confirmed in due course.

Venue and Contact


Tres Cantos, 

Hg3 Conferences Ltd

Tel: +44 (0)1423529333

Email: events@hg3.co.uk